Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'mutant idh1 inhibitor'

Search results for: 'mutant idh1 inhibitor'

Items 21-30 of 38

Page
per page
  1. S-Ruxolitinib (INCB018424)
    A4149 S-Ruxolitinib (INCB018424)
    Target: JAK
    Summary: JAK1/2 inhibitor,potent and selective
      Soluble in DMSO
  2. Tofacitinib (CP-690550,Tasocitinib)
    A4138 Tofacitinib (CP-690550,Tasocitinib)
     1 Citation
    Target: JAK
    Summary: Janus kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL
  3. Baricitinib (LY3009104, INCB028050)
    A4141 Baricitinib (LY3009104, INCB028050)
     2 Citation
    Summary: JAK1/JAK2 inhibitor,selective orally bioavailable
      insoluble in EtOH; insoluble in H2O; ≥18.57 mg/mL
  4. TG101209
    A4145 TG101209
    Summary: JAK2/3 inhibitor
      ≥25.5 mg/mL
  5. Ruxolitinib phosphate
    A3781 Ruxolitinib phosphate
    Summary: JAK1/JAK2 inhibitor
      ≥20.2 mg/mL
  6. SD 1008
    A4515 SD 1008
    Summary: Inhibitor of JAK2/STAT3 signaling pathway,apoptosis inducer
      <32.94 mg/mL
  7. TCS 21311
    A4516 TCS 21311
    Summary: JAK3 inhibitor
      <52.65 mg/mL
  8. CYT387 sulfate salt
    A3339 CYT387 sulfate salt
    Summary: JAK1/JAK2 inhibitor
      Soluble in DMSO
  9. JANEX-1
    A3515 JANEX-1
    Summary: JAK3 inhibitor
      insoluble in EtOH; ≥11.65 mg/mL
  10. Cercosporamide
    A4511 Cercosporamide
    Target: JAK|MNK
    Summary: Mnk2 and JAK3 inhibitor
      soluble in DMSO

Items 21-30 of 38

Page
per page